Cart
sales@molnova.com
VIP Receptor-Binding Inhibitor L-8-K
CAS No. 120550-85-8
VIP Receptor-Binding Inhibitor L-8-K( ——— )
Catalog No. M40489 CAS No. 120550-85-8
VIP Receptor-Binding Inhibitor L-8-K
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVIP Receptor-Binding Inhibitor L-8-K
-
NoteResearch use only, not for human use.
-
Brief DescriptionVIP Receptor-Binding Inhibitor L-8-K
-
DescriptionVIP Receptor-Binding Inhibitor L-8-K
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number120550-85-8
-
Formula Weight1028.29
-
Molecular FormulaC50H77N9O12S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
E-3030
E-3030 free acid is a potent dual activator of peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma, exhibiting significant antidiabetic and lipid-modulating effects. E-3030 decreases blood glucose, triglyceride, non-esterified fatty acids, and insulin levels, while increasing blood adiponectin levels. E-3030 improves glucose tolerance and shows remarkable triglyceride- and non-high-density lipoprotein cholesterol-lowering effects in animal models.
-
Azalein
Azalein
-
Kuraridine
Kuraridine is measured against cGMP PDE5 to identify potent cGMP specific phosphodiesterase type 5 inhibitory constituents.
